TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | -36.37%44.58B | ---- | ---- | ---- | 39.17%70.06B | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | ---122.99B | ---- | ---- | ---- | ---- | ---- | ---- |
Investment loss (gain) | ---- | ---- | ---- | 105.36%9.38B | ---- | ---- | ---- | 2.01%-174.81B | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | -138.63%-1.22B | ---- | ---- | ---- | --3.15B | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | -138.63%-1.22B | ---- | ---- | ---- | --3.15B | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | -5.20%5.02B | ---- | ---- | ---- | -0.69%5.29B | ---- | ---- |
-Depreciation | ---- | ---- | ---- | -5.20%5.02B | ---- | ---- | ---- | -0.69%5.29B | ---- | ---- |
Exchange Loss (gain) | ---- | ---- | ---- | 452.17%381M | ---- | ---- | ---- | 110.70%69M | ---- | ---- |
Special items | ---- | ---- | ---- | 0.49%460.5B | ---- | ---- | ---- | 9.06%458.27B | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 9.28%395.64B | ---- | ---- | ---- | 26.37%362.03B | ---- | ---- |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | ---- | ---- | -52.08%5.88B | ---- | ---- | ---- | -74.04%12.27B | ---- | ---- |
Financial assets at fair value (increase)decrease | ---- | ---- | ---- | 60.96%-13.78B | ---- | ---- | ---- | 20.75%-35.29B | ---- | ---- |
Financial liabilities at fair value (increase)decrease | ---- | ---- | ---- | -168.88%-2.19B | ---- | ---- | ---- | 314.82%3.18B | ---- | ---- |
Cash from business operations | ---- | ---- | ---- | 12.67%385.55B | ---- | ---- | ---- | 18.92%342.18B | ---- | ---- |
Other taxs | ---- | ---- | ---- | -205.50%-1.04B | ---- | ---- | ---- | 116.75%982M | ---- | ---- |
Dividend received - operating | ---- | ---- | ---- | -12.02%615M | ---- | ---- | ---- | -15.38%699M | ---- | ---- |
Interest received - operating | ---- | ---- | ---- | 35.47%7.32B | ---- | ---- | ---- | 43.91%5.4B | ---- | ---- |
Special items of business | ---- | 12.48%280.55B | ---- | -103.04%-8.08B | ---- | 6.84%249.42B | ---- | ---3.98B | ---- | 17.72%233.46B |
Adjustment items of business operations | 6.65%346.6B | ---- | 4.42%183.76B | ---- | 12.52%324.98B | ---- | 0.92%175.98B | ---- | 17.23%288.83B | ---- |
Net cash from operations | 6.65%346.6B | 12.48%280.55B | 4.42%183.76B | 11.32%384.37B | 12.52%324.98B | 6.84%249.42B | 0.92%175.98B | 20.54%345.28B | 17.23%288.83B | 17.72%233.46B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -3.46%75.18B | ---- | 2.92%145.82B | ---- | 3.04%77.87B | ---- | -0.44%141.68B | ---- | 11.91%75.57B |
Dividend received - investment | -2.21%133.76B | 8.60%13.69B | -12.89%36.38B | -2.79%33.37B | 1.70%136.78B | 1.83%12.61B | -8.27%41.77B | 6.69%34.33B | 10.76%134.5B | 34.19%12.38B |
Decrease in deposits (increase) | ---- | -195.91%-47.26B | ---- | 82.47%80.79B | ---- | 158.95%49.27B | ---- | 149.45%44.27B | ---- | 349.44%19.03B |
Sale of fixed assets | -47.06%45M | ---- | 155.00%51M | 189.53%1.05B | -42.57%85M | ---- | -25.93%20M | 6.45%363M | -40.08%148M | ---- |
Purchase of fixed assets | -28.22%-2.52B | ---- | -128.95%-1.65B | -35.60%-4.17B | -14.36%-1.97B | ---- | -30.32%-722M | 44.90%-3.08B | 44.64%-1.72B | ---- |
Sale of subsidiaries | --5.45B | ---- | 510.00%183M | ---- | ---- | ---- | --30M | ---- | -46.99%255M | ---- |
Acquisition of subsidiaries | 6.71%-10.27B | ---- | 37.06%-1.23B | ---- | 9.17%-11.01B | ---- | -1,436.22%-1.95B | ---- | 7.50%-12.12B | ---- |
Recovery of cash from investments | 75.95%1.7T | ---- | 45.72%531.12B | 2.73%1.02T | 3.57%963.8B | ---- | 5.00%364.49B | 60.07%991.81B | 89.90%930.54B | ---- |
Cash on investment | -52.06%-2.13T | -45.25%-1.27T | -22.04%-569.69B | -28.03%-1.72T | -29.75%-1.4T | -24.89%-872.41B | -36.19%-466.81B | -15.65%-1.34T | -25.22%-1.08T | -26.77%-698.52B |
Other items in the investment business | -138.73%-6.17B | 80.15%1.02T | 317.16%4.86B | 194.36%21.64B | 161.81%15.94B | 21.91%565.76B | 93.60%-2.24B | -921.47%-22.93B | 25.28%-25.79B | 68.11%464.08B |
Net cash from investment operations | -5.79%-315.47B | -23.61%-206.3B | 100.04%28M | -168.04%-424.24B | -445.97%-298.19B | -30.94%-166.9B | -557.69%-65.41B | 59.81%-158.27B | 81.88%-54.62B | 43.78%-127.46B |
Net cash before financing | 16.21%31.13B | -10.03%74.25B | 66.22%183.79B | -121.32%-39.87B | -88.56%26.79B | -22.14%82.53B | -41.39%110.57B | 274.14%187.01B | 525.68%234.21B | 473.29%106B |
Cash flow from financing activities | ||||||||||
New borrowing | -22.22%14M | ---- | ---- | -93.75%43M | --18M | --18M | --18M | 493.10%688M | ---- | ---- |
Refund | -6,139.25%-35.13B | -6,429.18%-35.13B | -25,079.86%-35B | 93.03%-577M | -480.41%-563M | -627.03%-538M | -101.45%-139M | -75,127.27%-8.28B | ---97M | ---74M |
Issuance of bonds | --35B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | -4.39%-5.14B | ---- | -4.98%-7.92B | ---- | 0.44%-4.93B | ---- | 8.20%-7.55B | ---- | -15.58%-4.95B |
Dividends paid - financing | 6.86%-18.76B | ---394M | 4.43%-3.17B | 24.27%-14.27B | 17.56%-20.14B | ---- | -6.93%-3.32B | -2.06%-18.84B | 3.83%-24.43B | -63.87%-313M |
Absorb investment income | -42.09%10.36B | 17.43%12.73B | 22.05%8.57B | 205.89%18.04B | 451.96%17.89B | --10.84B | --7.02B | -74.20%5.9B | -81.28%3.24B | ---- |
Other items of the financing business | -1,850.17%-95.75B | -414.67%-105.19B | 30.24%-48.04B | 172.88%66.11B | 103.57%5.47B | 69.30%-20.44B | 57.90%-68.86B | -177.89%-90.71B | -339.23%-153.08B | -241.87%-66.58B |
Net cash from financing operations | -3,996.26%-104.26B | -760.48%-133.62B | -18.93%-77.64B | 150.19%60.27B | 101.53%2.68B | 78.59%-15.53B | 60.85%-65.28B | -207.98%-120.1B | -411.95%-174.36B | -235.36%-72.53B |
Effect of rate | -128.04%-30M | -91.23%10M | 136.11%13M | -70.51%64M | -53.07%107M | -44.39%114M | -28.57%-36M | 405.63%217M | 860.00%228M | 639.47%205M |
Net Cash | -348.18%-73.13B | -188.61%-59.37B | 134.39%106.14B | -69.51%20.4B | -50.77%29.47B | 100.17%67B | 106.47%45.28B | 1,649.03%66.92B | 6,747.83%59.85B | 32.88%33.47B |
Begining period cash | 16.04%148.06B | 16.04%148.06B | 16.04%148.06B | 111.04%127.59B | 111.04%127.59B | 111.04%127.59B | 111.04%127.59B | 6.62%60.46B | 6.71%60.46B | 6.76%60.46B |
Cash at the end | -52.34%74.9B | -54.44%88.7B | 47.08%254.22B | 16.04%148.06B | 30.39%157.17B | 106.84%194.71B | 109.85%172.84B | 111.04%127.59B | 109.63%120.54B | 15.11%94.14B |
Cash balance analysis | ||||||||||
Bank deposits | ---- | 1,931.11%914M | ---- | -86.34%608M | ---- | --45M | ---- | 2,319.57%4.45B | ---- | ---- |
Cash and cash equivalent balance | ---- | 1,931.11%914M | ---- | -86.34%608M | ---- | --45M | ---- | 2,319.57%4.45B | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.